Pfizer COVID-19 Vaccine: Efficacy in Children 5-11 Years

Getty Images

Pfizer and its partner BioNTech announced that their COVID-19 vaccine for children ages 5 to 11 is over 90% effective.

Great news has been released this Friday about the vaccine developed jointly by Pfizer and BioNTech against COVID-19 for children, since this medicine exceeds 90% effectiveness in children from 3 to 11 years old, according to the statement released by the US Food and Drug Administration (FDA).

As reported by NPR, this document with information from Pfizer is a kind of prelude to the meeting that next Tuesday will be led by expert advisers from the FDA to analyze and draw final conclusions about the vaccine for the most children.

If the FDA finally authorizes the vaccines, the Centers for Disease Control and Prevention (CDC) will later define who should receive them in early November, according to CNBC.

The Pfizer / BioNTech COVID-19 Vaccine Study for Children of Children Ages 5 to 11 Yields Greater Than 90% Efficacy: How It Was Done and What Doses They Used

NPR reports that Pfizer and BioNTech studied a 10-microgram vaccine dose in children ages 5 to 11, which is equivalent to one-third of the dose used for adults and older children.

The lowest dose was chosen to minimize side effects and because it still elicits a strong immune response, the companies said.

In the main clinical trial conducted by the companies, the vaccine appeared to be more than 90% effective against symptomatic COVID-19, according to a statement released by the FDA.

The study also highlights that no cases of cardiac inflammation were seen, but only a few thousand children were included in the research, and thus this rare condition may not be detectable.

The vaccines could be given from the beginning of November, and the first children from 5 to 11 years would be protected against COVID-19 before Christmas

According to CNBC, it only remains for local regulators to authorize Pfizer / BioNTech vaccines for use in children ages 5 to 11 in the United States.

If this happens, minors could celebrate Christmas already protected against a possible contagion of Coronavirus.

As of this writing, the FDA was expected to release its independent review of Pfizer’s safety and efficacy data on Friday.

More than 25,000 pediatricians and primary care providers have already signed up to receive the vaccines and give them to the little ones, reports CNBC.

Do you agree to give COVID-19 vaccines to children from 5 to 11 years old?

READ MORE: Salmonella outbreak in the US: 37 states recall imported onions: Where did they come from?

Follow Now Same on Instagram


.